Publicaciones en colaboración con investigadores/as de Hammersmith Hospital (12)

2024

  1. Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver Malignancy

    Journal of Vascular and Interventional Radiology, Vol. 35, Núm. 9, pp. 1253-1267.e1

2023

  1. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

    The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422

  2. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

    ESMO Open, Vol. 8, Núm. 3

2022

  1. De Novo Malignancy after Liver Transplantation: Risk Assessment, Prevention, and Management - Guidelines from the ILTS-SETH Consensus Conference

    Transplantation, Vol. 106, Núm. 1, pp. E30-E45

2017

  1. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: Expert consensus

    Journal of Gastrointestinal Oncology, Vol. 8, Núm. 6, pp. 1079-1099

2015

  1. Cost-effectiveness of selective internal radiation therapy using yttrium-90 resin microspheres in treating patients with inoperable colorectal liver metastases in the UK

    Journal of Medical Economics, Vol. 18, Núm. 10, pp. 797-804

2012

  1. Integrating radioembolization ( 90Y Microspheres) into current treatment options for liver tumors: Introduction to the international working group report

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 35, Núm. 1, pp. 81-90

  2. Integrating radioembolization into the treatment paradigm for metastatic neuroendocrine tumors in the liver

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 35, Núm. 4, pp. 393-398

  3. Integrating radioembolization with chemotherapy in the treatment paradigm for unresectable colorectal liver metastases

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 35, Núm. 3, pp. 293-301

  4. Radioembolization for the treatment of liver tumors: General principles

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 35, Núm. 1, pp. 91-99

2011

  1. General selection criteria of patients for radioembolization of liver tumors: An international working group report

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 34, Núm. 3, pp. 337-341

  2. Radioembolization for hepatocellular carcinoma: A review of the evidence and treatment recommendations

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 34, Núm. 4, pp. 422-431